The report scope includes detailed competitive outlook covering market shares and profiles key participants in the global Generic Drugs market share. Major industry players with significant revenue share include Sun Pharmaceutical Industries Ltd., Aurbindo Pharma, Aspen Pharmacare, Fresenius Kabi Ag, Lupin, Endo Pharma, Teva Pharmaceuticals, Mylan NV, Sandoz (Novartis), Hospira (Pfizer Inc.), and others.
The Generic Drugs Market is expected to exceed more than US$ 688 Billion by 2024 at a CAGR of 8.7% in the given forecast period.
FYI, You will get latest updated report as per the COVID-19 Impact on this industry. Our updated reports will now feature detailed analysis that will help you make critical decisions.
Browse Full Report: https://www.marketresearchengine.com/generic-drugs-market
The global Generic Drugs market report provides geographic analysis covering regions, such as North America, Europe, Asia-Pacific, and Rest of the World. The Generic Drugs market for each region is further segmented for major countries including the U.S., Canada, Germany, the U.K., France, Italy, China, India, Japan, Brazil, South Africa, and others.
The global Generic Drugs market is segregated on the basis of Distribution Channel as Hospital Pharmacies and Retail Pharmacies. Based on Therapy Area the global Generic Drugs market is segmented in Respiratory, Genitourinary/Hormonal, Rheumatology, Diabetes, Oncology, Central nervous system (CNS), Cardiovascular, Dermatology, and Others. Based on Drug Delivery the global Generic Drugs market is segmented in Dermal/Topical, Inhalers, Oral, and Injectables.
The market for the generic drug has been driven by new government activities to manufacture generic drugs and mainly to promote the use of generic drugs against deadly chronic diseases globally. The low cost of generic drugs is majorly responsible for thickening the growth of generic drugs market in new emerging markets of developing economies.
Generic drugs are artificially indistinguishable from their branded drug partners. Although generics are bioequivalent to the drugs that are branded, they are sold at a critical discount from branded drugs costs. According to the FDA endorsement, the Generic drugs ought to contain a similar dynamic fixing as their marked partner; it ought to be bioequivalent and should meet group necessities for character, quality, immaculateness, and quality. It ought to be indistinguishable on the course of administration and dose structure.
Sun Pharmaceutical Industries Ltd., Aurbindo Pharma, Aspen Pharmacare, Fresenius Kabi Ag, Lupin, Endo Pharma, Teva Pharmaceuticals, Mylan NV, Sandoz (Novartis), Hospira (Pfizer Inc.), and others are among the major players in the global Generic Drugs market. The companies are involved in several growth and expansion strategies to gain a competitive advantage. Industry participants also follow value chain integration with business operations in multiple stages of the value chain.
The Generic Drugs Market has been segmented as below:
The Generic Drugs Market is segmented on the lines of Generic Drugs Market, By Distribution Channel, Generic Drugs Market, By Therapy Area, Generic Drugs Market, By Drug Delivery, Generic Drugs Market, By Region and Generic Drugs Market, By Company.
Generic Drugs Market, By Distribution Channel this market is segmented on the basis of Hospital Pharmacies and Retail Pharmacies. Generic Drugs Market, By Therapy Area this market is segmented on the basis of Respiratory, Genitourinary/Hormonal, Rheumatology, Diabetes, Oncology, Central nervous system (CNS), Cardiovascular, Dermatology and Others. Generic Drugs Market, By Drug Delivery this market is segmented on the basis of Dermal/Topical, Inhalers, Oral and Injectables. Generic Drugs Market, By Region this market is segmented on the basis of North America, Europe, Asia-Pacific and Rest of the World. Generic Drugs Market, By Company this market is segmented on the basis of Sun Pharmaceutical Industries Ltd., Aurbindo Pharma, Aspen Pharmacare, Fresenius Kabi Ag, Lupin, Endo Pharma, Teva Pharmaceuticals, Mylan NV, Sandoz (Novartis) and Hospira (Pfizer Inc.).
The report covers:
- Global Generic Drugs market sizes from 2015 to 2024, along with CAGR for 2018-2024
- Market size comparison for 2017 vs 2024, with actual data for 2017, estimates for 2018 and forecast from 2019 to 2024
- Global Generic Drugs market trends, covering comprehensive range of consumer trends & manufacturer trends
- Value chain analysis covering participants from raw material suppliers to the downstream buyer in the global Generic Drugs market
- Major market opportunities and challenges in forecast timeframe to be focused
- Competitive landscape with analysis on competition pattern, portfolio comparisons, development trends and strategic management
- Comprehensive company profiles of the key industry players
The global Generic Drugs market report scope includes detailed study covering underlying factors influencing the industry trends.
The report covers analysis on regional and country level market dynamics. The scope also covers competitive overview providing company market shares along with company profiles for major revenue contributing companies.
Reasons to Buy this Report:
- Gain detailed insights on the Generic Drugs industry trends
- Find complete analysis on the market status
- Identify the Generic Drugs market opportunities and growth segments
- Analyse competitive dynamics by evaluating business segments & product portfolios
- Facilitate strategy planning and industry dynamics to enhance decision making
Request Sample Report from here: https://www.marketresearchengine.com/generic-drugs-market
Table of Contents:
- Research Methodology
- Executive Summary
- Market Overview
4.2 Porter’s Five Force Analysis
- Generic Drugs Market, By Distribution Channel
- Generic Drugs Market, By Therapy Area
- Generic Drugs Market, By Drug Delivery
- Generic Drugs Market, By Geography
- Competitive Insights
- Company Profiles
10.1 Sun Pharmaceutical Industries Ltd.
10.1.1 Company Overview
10.1.2 Product/Service Landscape
10.1.3 Financial Overview
10.1.4 Recent Developments
10.2 Aurbindo Pharma
10.2.1 Company Overview
10.2.2 Product/Service Landscape
10.2.3 Financial Overview
10.2.4 Recent Developments
10.3 Aspen Pharmacare
10.3.1 Company Overview
10.3.2 Product/Service Landscape
10.3.3 Financial Overview
10.3.4 Recent Developments
10.4 Fresenius Kabi Ag
10.4.1 Company Overview
10.4.2 Product/Service Landscape
10.4.3 Financial Overview
10.4.4 Recent Developments
10.5.1 Company Overview
10.5.2 Product/Service Landscape
10.5.3 Financial Overview
10.5.4 Recent Developments
10.6 Endo Pharma
10.6.1 Company Overview
10.6.2 Product/Service Landscape
10.6.3 Financial Overview
10.6.4 Recent Developments
10.7 Teva Pharmaceuticals
10.7.1 Company Overview
10.7.2 Product/Service Landscape
10.7.3 Financial Overview
10.7.4 Recent Developments
10.8 Mylan NV
10.8.1 Company Overview
10.8.2 Product/Service Landscape
10.8.3 Financial Overview
10.8.4 Recent Developments
10.9 Sandoz (Novartis)
10.9.1 Company Overview
10.9.2 Product/Service Landscape
10.9.3 Financial Overview
10.9.4 Recent Developments
10.10 Hospira (Pfizer Inc.)
10.10.1 Company Overview
10.10.2 Product/Service Landscape
10.10.3 Financial Overview
10.10.4 Recent Developments
Other Related Market Research Reports:
Market Research Engine is a global market research and consulting organization. We provide market intelligence in emerging, niche technologies and markets. Our market analysis powered by rigorous methodology and quality metrics provide information and forecasts across emerging markets, emerging technologies and emerging business models. Our deep focus on industry verticals and country reports help our clients to identify opportunities and develop business strategies.
Company Name: Market Research Engine
Contact Person: John Bay
Country: United States